Skip to main content
Premium Trial:

Request an Annual Quote

UnitedHealthcare Agrees to Cover Paradigm Cancer Diagnostic

NEW YORK (GenomeWeb) – Molecular diagnostics developer Paradigm announced today that it has reached an agreement with UnitedHealthcare for insurance coverage of its next-generation sequencing-based cancer diagnostic test PCDx.

The diagnostic is designed to identify the genomic and proteomic alterations underlying a patient's tumor DNA, RNA, and proteins, leading to a more personalized and targeted approach to treatment.

"We continue to make excellent progress in our discussions with provider networks to ensure our best-in-class NGS test is available to the millions of Americans who are suffering with cancer," Paradigm CEO Robert Penny said in a statement. "With this contract, millions of patients and their treating clinicians will have access to our leading oncology testing service and make possible more informed and individually tailored treatment strategies."

Paradigm has signed similar coverage agreements with other insurers in recent months, including Atlanta-based Stratose in July and the Three Rivers Provider Network in August.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.